Pentagon spends $442.1 million on Pfizer antiviral pills
The U.S. Department of Defense announced a $442.1-million contract with Pfizer to produce 835,000 doses of Paxlovid, the first oral antiviral authorized to treat Covid-19.
Pfizer CEO Albert Bourla said on Monday he expected distribution of the pill to rise "exponentially" in the coming months, with 6 million courses available by March.
The Pentagon's announcement came less than a week after the White House announced it would double its purchase of Paxlovid from 10 million to 20 million treatment courses, with 10 million treatment courses ready by June.
The estimated completion for the Pentagon's contract was set for the end of March, officials said on Monday.
ABC News' Sasha Pezenik